J Doescher
Overview
Explore the profile of J Doescher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vahl J, von Witzleben A, Welke C, Doescher J, Theodoraki M, Brand M, et al.
Eur Arch Otorhinolaryngol
. 2021 Apr;
278(11):4535-4543.
PMID: 33877433
Purpose: Cancer patients have to overcome various barriers to obtain diagnostics and treatment at head and neck cancer centers. Travel distance to a specialized hospital may result in psychosocial and...
2.
Laban S, Brand M, Ezic J, Doescher J, Volkel G, Kestler H, et al.
HNO
. 2020 Nov;
69(4):249-255.
PMID: 33215226
Background: Etiologically, oropharyngeal squamous cell carcinoma (OPSCC) can be divided into OPSCC caused by noxious agents and human papillomavirus (HPV)-driven carcinoma. These types differ with regard to clinical features and...
3.
Meyer M, Arolt C, Kansy B, Doescher J, Quaas A, Beutner D, et al.
HNO
. 2020 Sep;
68(12):927-934.
PMID: 32929519
Introduction: Salivary gland carcinomas (SGCs) are rare tumors which represent a challenge for diagnosis and therapy due to their histological diversity and the different disease courses depending on the respective...
4.
Jeske S, Schuler P, Doescher J, Theodoraki M, Laban S, Brunner C, et al.
Immun Ageing
. 2020 Feb;
17:3.
PMID: 32082401
Introduction: The number of aging cancer patients has increased continuously and will do so further in the future. The immune system of elderly people experiences critical changes over the time....
5.
Doescher J, Schuler P, Greve J, Meyer M, Weissinger S, Hoffmann T, et al.
HNO
. 2019 Oct;
67(12):931-934.
PMID: 31628530
Background: Due to their comparatively low incidence, salivary gland carcinomas have only been the subject of isolated clinical studies in recent years. In addition, surgery with/without adjuvant radiotherapy is considered...
6.
Doescher J, Busch C, Wollenberg B, Dietz A, Wurdemann N, Schuler P, et al.
HNO
. 2019 Oct;
67(12):905-911.
PMID: 31612261
Background: In the field of immunotherapy of head and neck squamous cell carcinoma (HNSCC), a high level of study activity can still be observed. The results of the Keynote-048 study...
7.
Wigand M, Jeske S, Hahn J, Doescher J, Laban S, Hoffmann T, et al.
HNO
. 2019 Sep;
68(3):177-183.
PMID: 31559466
Physiological aging processes of the immune system are associated with an increased susceptibility to infectious, autoimmune and tumor diseases. In accordance with the general demographic development the number of tumor...
8.
Mytilineos D, Hoffmann T, Brunner C, Weissinger S, Moller P, Doescher J
HNO
. 2019 Jun;
67(12):948-951.
PMID: 31187149
This article presents an oncologic patient with oropharyngeal cancer. After surgery with bilateral neck dissection and adjuvant radiation, the patient developed foreign body granuloma in the area of neck dissection...
9.
Laban S, Doescher J, Busch C, Wollenberg B, Dietz A, Wurdemann N, et al.
HNO
. 2018 Nov;
66(12):880-887.
PMID: 30402813
Background: Immunotherapeutic strategies are becoming increasingly more important for head and neck cancer and numerous clinical trials were presented at the annual meeting of the American Society of Clinical Oncology...
10.
Doescher J, Jeske S, Weissinger S, Brunner C, Laban S, Bolke E, et al.
Strahlenther Onkol
. 2018 Apr;
194(5):392-402.
PMID: 29663037
Background: For head and neck squamous cell cancer (HNSCC), standard therapy consists of surgery, radiation, and/or chemotherapy. Antineoplastic immunotherapy could be an option in an adjuvant setting and is already...